The Global Synthetic Biology Market, by Product Type (Oligonucleotides, Enzymes, Cloning and Assembly Kits, Xeno-nucleic Acids (XNA), and Chassis Organism), by Technology (Gene Synthesis, Next-generation Sequencing, Cloning & Sequencing, Bioinformatics, Microfluidics, Nanotechnology, Site-saturation Mutagenesis, and Mathematical Modeling), by Application (Medical Applications (Drug Discovery & Therapeutics and Artificial Tissue & Tissue Regeneration), Industrial Applications (Biomaterials & Green Chemicals, Industrial Enzymes, and Biofuels & Renewable Energy), and Environmental Applications (Bioremediation and Whole-cell Biosensors)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 6.0 billion in 2021, and is projected to exhibit a CAGR of 33.9% during the forecast period (2022 – 2028).
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Key players are involved adopting inorganic growth strategies such as collaboration and partnership, in order to enhance the market presence. For instance, in April 2018, Twist Bioscience Corporation expanded its presence in Asia Pacific through strategic distribution partners for marketing of synthetic DNA, exome, and custom target enrichment product suite for next-generation sequencing. These partners include Recenttec K.K., DNA Link, and its subsidiary LnCBio Inc., Premas Life Sciences, and BioArrow Technology Limited. Moreover, in January 2015, AstraZeneca collaborated with Thermo Fisher Scientific. Under this collaboration, Thermo Fisher agreed to provide RNA-guide libraries that targets individual known human genes and gene families. Moreover, in July 2017, Quintara Biosciences partnered with Twist Bioscience to launch two new services— qBlock Gene Fragments and qGene DNA cloning.
Moreover, key companies are focused on mergers and acquisitions, in order to expand their market presence. For instance, in April 2018, Danaher Corporation completed the acquisition of Integrated DNA Technologies, Inc. for deal value of around US$ 2.1 billion. Integrated DNA Technologies, Inc. (IDT) is a provider of consumables for genomics applications in molecular biology, quantitative Polymerase Chain Reaction (qPCR), next generation sequencing (NGS), synthetic biology, gene editing, and molecular diagnostics.
Ask for PDF Brochure @
The global synthetic biology market is expected to exhibit a CAGR of 33.9% during the forecast period, owing to rising research & development funding and increasing entry of synthetic biology start-up in these market.
On the basis of product type, oligonucleotides segment accounted for major market share in 2017. Demand for oligonucleotides will be propelled during the forecast period, owing to emergence of several promising concepts to produce oligonucleotides in cost-effective manner. For instance, in-situ microarray synthesis of oligonucleotides have gained traction as it enables oligo-sequences to be generated in a parallel and miniaturized fashion and offer advantages in throughput and reagent consumption.
On the basis of technology, gene synthesis segment accounted for the largest share in 2017. Gene synthesis has been used for the development of synthetic biology applications. The reductions in the production costs of genes and associated raw materials such as oligonucleotides, are driving demand for synthetic biology products.
On the basis of application, medical applications segment accounted for the largest share in 2017. Synthetic biology has various medical applications in cancer therapy, personalized medicine, drug discovery and development, and regenerative medicine. Furthermore, increasing engagement of research universities, government investments and rapidly declining costs of gene sequencing are supporting growth of the medical applications segment in the synthetic biology market.
Major players operating in the global synthetic biology market include Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Genscript Biotech Corporation, Codexis, Inc., Amyris, Inc., Danaher Corporation (Integrated DNA Technologies, Inc.), EnBiotix, Inc., Evonetix Ltd., Ginkgo Bioworks, Inc., and Prokarium.
Reasons to Buy this Synthetic Biology Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Synthetic Biology market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Synthetic Biology market
➡Leading company profiles reveal details of key Synthetic Biology market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Synthetic Biology market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Synthetic Biology Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Synthetic Biology Industry Impact
Chapter 2 Global Synthetic Biology Competition by Types, Applications, and Top Regions and Countries
2.1 Global Synthetic Biology (Volume and Value) by Type
2.3 Global Synthetic Biology (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Synthetic Biology Sales, Consumption, Export, Import by Regions
Chapter 5 North America Synthetic Biology Market Analysis
Chapter 6 East Asia Synthetic Biology Market Analysis
Chapter 7 Europe Synthetic Biology Market Analysis
Chapter 8 South Asia Synthetic Biology Market Analysis
Chapter 9 Southeast Asia Synthetic Biology Market Analysis
Chapter 10 Middle East Synthetic Biology Market Analysis
Chapter 11 Africa Synthetic Biology Market Analysis
Chapter 12 Oceania Synthetic Biology Market Analysis
Chapter 13 South America Synthetic Biology Market Analysis
Chapter 14 Company Profiles and Key Figures in Synthetic Biology Business
Chapter 15 Global Synthetic Biology Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027